Mukai, Hirofumi
Kogawa, Takahiro
Matsubara, Nobuaki
Naito, Yoichi
Sasaki, Masaoki
Hosono, Ako
Article History
Received: 27 October 2016
Accepted: 28 December 2016
First Online: 4 January 2017
Compliance with ethical standards
:
: This study was sponsored by Kowa Company, Ltd., Aichi, Japan.
: Prior to the study, the Institutional Review Board at the National Cancer Center Hospital East approved the protocol and the informed consent document. Written informed consent was obtained from all patients enrolled into the study. Patients starting the second and subsequent courses of treatment provided their written re-consent. This study was conducted in accordance with the protocol, International Conference on Harmonization (ICH) Good Clinical Practice guidelines, the Declaration of Helsinki, and all applicable local and national legislation.